(firstQuint)The DDI Study of SP2086 and Simvastatin.

 This is an open-label (volunteers will know the names of treatments they are assigned) single-center study of SP2086 and Simvastatin in healthy adult volunteers.

 SP2086 will be administered orally (by mouth) as 100 mg on Days 4, 5, 6, 7, and 8 and Simvastatin will be administered orally as two 20mg tablets on Days 1 and 8.

 Both SP2086 and Simvastatin tablets will be taken with 8 ounces (240 mL) of water.

.

 The DDI Study of SP2086 and Simvastatin@highlight

The purpose of the study is to investigate the potential interaction between multiple oral doses of SP2086 and a single oral dose of Simvastatin in healthy adult volunteers.

